Thermo Fischer to Buy Patheon in $7.2 Billion Deal

Pantheon is being acquired for $7.2 million, including $2 billion in debt. Pantheon is a pharmaceutical development and manufacturing services company, while Thermo Fisher manufactures scientific instruments and chemicals. The acquisition is expected to increase Thermo Fisher's adjusted EPS by $0.30 for the full year, with the total acquisition cost being $7.2 billion.

How much is Thermo Fisher expecting to add to its adjusted EPS after the acquisition?

What is the total number mentioned in relation to the acquisition?